Disclosure NewswireTMiCrowdNewswire - May 1, 2017
May 1, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring Antares Pharma Inc. (NASDAQ:ATRS) in real time and just received an alert that ATRS is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 2194100 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $3.15. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net .
From August 2009 to April 2017, an aggregate amount of 753583823 shares of ATRS have been shorted for a total dollar value of $2260751469. The ATRS SqueezeTrigger price of $3.15 is the volume weighted average price that all shorts are short in shares of ATRS. There is still approximately $6,933,356 of potential short covering in shares of ATRS.
Buyins.net has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.buyins.net .
Antares Pharma Inc. (NASDAQ:ATRS) – Altiris, Inc., incorporated in August 1998, is a provider of service-oriented management software products and services that enable organizations to manage information technology (IT) assets throughout their lifecycles. The Company’s integrated lifecycle management solutions are designed to address the challenges that IT professionals face in deploying, migrating, backing up and restoring software settings on multiple hardware devices; provisioning and managing servers; tracking performance and diagnostic metrics for hardware and software; taking inventory of existing IT assets; accessing security compliance and vulnerabilities; managing patches and updates, and facilitating problem resolution for hardware or software failures. Altiris markets its software products through original equipment manufacturers, systems integrators, software distributors and directly to end user licensees. As of December 31, 2005, the Company had licensed its products to customers in industries, such as communications, energy, financial/consulting services, healthcare/pharmaceuticals, IT, insurance and manufacturing/retail.
The Company’s primary product suites are Total Management Suite, Client Management Suite, Server Management Suite, Service and Asset Management Suite, License Compliance Suite, Migration Suite, and Handheld Management Suite. These suites consist of modules that provide comprehensive functionality for managing the critical aspects of the IT lifecycle. These suites are the modules enabling IT professionals to deploy, migrate, patch, restore and audit software on servers, desktop and notebook computers, and mobile devices. Using the Altiris suites or modules, IT professionals can also track performance and diagnostic metrics of hardware and software, and determine what IT assets reside in the enterprise. The suites or modules facilitate end user problem resolution by providing IT professionals with remote access capabilities and allowing them to correct software configuration problems. Finally, Altiris provide solutions that allow its customers to perform security audits and access vulnerabilities within their IT environment.
The Altiris service-oriented management solution automates the manual processes associated with initial deployment, system migration, ongoing maintenance and security, service, asset management, problem resolution, and migration of software. The Company’s customers can access these capabilities from any Web browser on a range of devices, including desktops, laptops and personal digital assistants. Using the Altiris products, customers can increase the productivity of their IT professionals and reduce overall IT costs. In addition, by improving utilization of purchased technology and reducing IT infrastructure downtime, the Company’s solution enables its customers to leverage their existing IT assets. As a result, customers can realize a rapid return on their investment in the Company’s products and an improved returns on their other IT investments. Altiris products are licensed to customers as integrated suites or as separate modules designed to help customers better align IT services to business initiatives through automated operations, audit-ready security and lifecycle integration, depending on customer requirements.
The Company’s customer services group provides all of its customers with complementary access to its user forum. For customers needing a higher level of support, Altiris provides a range of services that includes onsite services, training and education, and premium support. The Company provides customer services from its headquarters in Lindon, Utah, and other support offices located in Newton, Massachusetts; Plymouth, Michigan; Sydney, Australia and Tallinn, Estonia.
Onsite professional services offered by Altiris include pre- and post-sales consulting services, as well as implementation and integration assistance. Consulting services include planning, simple designing and integration performed by the Company’s consultants or software.
The SqueezeTrigger database of billions of short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor – Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new “Fair Market Making Requirements”
Naked Shorts (RegSho) – Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
Earnings – Predicts probability, price move and length of move before and after all US stock earnings reports
Seasonality – Predicts probability, price move and length of move based on exact time of year for all US stocks
Group Correlation – Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups
SqueezeTrigger – Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Valuation – Tracks all known valuation models and applies them.
GATS – Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies.
PatternScan – Automates tracking of every technical pattern and predicts next move in stocks.
Insider – Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders
Events – Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Tom Ronk, CEO